Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil

doi:10.1038/s41591-022-01701-w

Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	838-843
Number of pages	6
Journal	Nature Medicine
Volume	28
Issue number	4
DOIs	https://doi.org/10.1038/s41591-022-01701-w
Publication status	Published - Apr 2022
Externally published	Yes

ASJC Scopus Subject Areas

General Biochemistry,Genetics and Molecular Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41591-022-01701-w

Cite this

@article{3c6997b25ab8413d8b394dad9e03bb01,

title = "Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = apr,

doi = "10.1038/s41591-022-01701-w",

language = "English",

volume = "28",

pages = "838--843",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85124416451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124416451&partnerID=8YFLogxK

U2 - 10.1038/s41591-022-01701-w

DO - 10.1038/s41591-022-01701-w

M3 - Article

C2 - 35140406

AN - SCOPUS:85124416451

SN - 1078-8956

VL - 28

SP - 838

EP - 843

JO - Nature Medicine

JF - Nature Medicine

IS - 4

ER -

Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this